Curtin F, Champion B, Davoren P, Duke S, et al. A Safety and Pharmacodynamics Study of Temelimab, an anti-HERV-W-Env Monoclonal Antibody, in Type 1 Diabetes Patients. Diabetes Obes Metab 2020 Feb 19. doi: 10.1111/dom.14010.
PMID: 32077207